Tirzepatide Injection Program

 ✓ Standard Formula. A straightforward tirzepatide program for patients exploring weight management treatment options.

If you are located in one of the states listed above, contact us to discuss other available treatment options.

Choosing tirzepatide for weight management marks the beginning of a new phase in your health journey. It’s common to feel both motivated and cautious when starting something new.

At Invyncible, we make the process clear and guided. Tirzepatide is a compounded GLP-1/GIP option that works through multiple pathways to help regulate appetite, slow digestion, and support steady progress over time.

Program Options

• Program 1: ~2.25 mg weekly / 9 mg vial → ~4 weeks
• Program 2: ~4.5 mg weekly / 18 mg vial → ~4 weeks
• Program 3: ~6.75 mg weekly / 27 mg vial → ~4 weeks
• Program 4: ~9 mg weekly / 36 mg vial → ~4 weeks
• Program 5: ~11.25 mg weekly / 45 mg vial → ~4 weeks

⚠️ Examples only. Your provider will determine the exact dosing schedule and vial size appropriate for your treatment plan.

Your Care Journey

• Start Intake – Complete secure health profile
• Consult With Provider – Licensed provider reviews and prescribes if appropriate
• Pharmacy Coordination – Prescription filled by an independent compounding pharmacy, or coordinated with another licensed pharmacy if you have a preference.
• Treatment Begins – Clear instructions shipped with your program
• Ongoing Support – Provider remains available for check-ins and adjustments

What We Do / Don’t Do

We Do:

• Provide telemedicine consultations
• Offer structured programs
• Coordinate with licensed pharmacies

We Don’t:

• Compound or dispense medications
• Sell medications directly

Side Effects

Common: nausea, vomiting, diarrhea, constipation, stomach pain, reflux, injection site reactions.
Less common but serious: pancreatitis, gallbladder disease, thyroid tumors, kidney issues.
⚠️ This is not complete. Review full pharmacy documentation and consult your provider.

Important

• Compounded versions of Tirzepatide are not FDA-approved. Neither the FDA nor any other regulatory agency has reviewed these products for safety, quality, or effectiveness.
• Invyncible is a telemedicine provider network, not a pharmacy. Prescriptions are filled by licensed pharmacies.
• Important safety statement: This program is not intended to diagnose, treat, cure, or prevent any disease. Consult a licensed provider if pregnant, breastfeeding, or managing chronic conditions.

Questions?

If you have questions about programs, vial size, or treatment, our team is here.

Email | Call | Live Chat